Australia markets closed

Onward Medical N.V. (63E.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6700+0.0600 (+1.30%)
As of 09:59AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 170.37M
Enterprise value 157.48M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.90
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.58

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-3.76%
S&P500 52-week change 324.96%
52-week high 36.5400
52-week low 31.9950
50-day moving average 34.8538
200-day moving average 34.0063

Share statistics

Avg vol (3-month) 3114
Avg vol (10-day) 3N/A
Shares outstanding 534.63M
Implied shares outstanding 636.36M
Float 814.56M
% held by insiders 118.94%
% held by institutions 137.19%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)4,212.88%

Management effectiveness

Return on assets (ttm)-36.87%
Return on equity (ttm)-102.55%

Income statement

Revenue (ttm)532k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -35.23M
Net income avi to common (ttm)-36.18M
Diluted EPS (ttm)-1.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)29.77M
Total cash per share (mrq)0.99
Total debt (mrq)16.87M
Total debt/equity (mrq)94.11%
Current ratio (mrq)4.70
Book value per share (mrq)0.59

Cash flow statement

Operating cash flow (ttm)-32.27M
Levered free cash flow (ttm)-21.08M